Request Trial
shutterstock_1191925942_canna_obscura
Canna Obscura / Shutterstock.com
11 August 2022Staff writer

Hemp group in cybersquatting clash

Illinois-based firm accuses hemp group of cybersquatting | US Court for the District of Colorado.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
Could everyday hospital equipment be the next defence against counterfeit medicines?
23 February 2026   A new study suggests the equipment already found in hospitals worldwide could offer a front line against fake vaccines and insulin.
Americas
BioNTech fires shots at Moderna's next-generation vaccine
20 February 2026   The German biotech claims the newly approved vaccine infringes its mRNA patent, deepening an already complex feud with billions of dollars at stake.
Careers
Mintz gains ex-Winston & Strawn partner and ITC expert
20 February 2026   The new hire has “deep experience in high-stakes International Trade Commission proceedings”, whose specialisms include medical devices, pharma and genomics.


Editor's picks

Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026

Editor's picks

Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026
Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025

More features

Could everyday hospital equipment be the next defence against counterfeit medicines?
BioNTech fires shots at Moderna's next-generation vaccine
Mintz gains ex-Winston & Strawn partner and ITC expert
Abbott unit defends European protection for heart valve ‘cuff’ design
Natera targets ex-employee over mass file download before rival move
Hogan Lovells makes senior public and administrative hire in Italy
Danaher moves to acquire Masimo in $9.9bn deal
Generic rival blocked as AZ defends diabetes stronghold